Amplify: A randomized, phase iii study evaluating the efficacy and safety of aclidinium/formoterol versus monotherapy in patients with copd

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2018
This article has no abstract
Epistemonikos ID: 10f55044ff8cc2a1f4752ea37a80ab253d05b975
First added on: Feb 09, 2025